Luminex, Bio-Rad Extend Deal, Includes Magpix System | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today announced the expansion of a global sales and distribution deal with Bio-Rad Laboratories to 2023 as well as the granting of the global sales and distribution rights for the Magpix multiplexing platform.

Under the terms of the agreement Bio-Rad will offer Luminex's xMAP systems, including the Magpix system, which detects up to 50 different analytes on a single sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.